跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AURO PIPTAZ 2 g/0.25 g piperacillin 2g (as sodium) and tazobactam 250mg (as sodium) powder for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
AURO PIPTAZ 2 g/0.25 g piperacillin 2g (as sodium) and tazobactam 250mg (as sodium) powder for injection vial
Approved
STANDARD
AURO PIPTAZ 2 g/0.25 g piperacillin 2g (as sodium) and tazobactam 250mg (as sodium) powder for injection vial
Strides Pharma Science Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
c3af07ae0d28d7a6
Company
Strides Pharma Science Pty Ltd
Type
Standard
Approval Details
Approval Id
c3af07ae0d28d7a6
Product Name
AURO PIPTAZ 2 g/0.25 g piperacillin 2g (as sodium) and tazobactam 250mg (as sodium) powder for injection vial
Artg Id
162911
Artg Name
AURO PIPTAZ 2 g/0.25 g piperacillin 2g (as sodium) and tazobactam 250mg (as sodium) powder for injection vial
Sponsor
Strides Pharma Science Pty Ltd
Company Detail Path
/organization/strides-pharma-science-pty-ltd
Artg Date
2011-09-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
c3af07ae0d28d7a6
Type
Standard
Back to TGA Approvals